Insider Trades47 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 | Sell | ACRS | Roland Wilhelm Kolbeck | Chief Scientific Officer | 12,385 | $5.20 | $783.1M | -19.39% | +205.75% | $64.4K | -8.51% | — | Stalk |
| May 1, 2026 | Sell | ACRS | Jesse Wayne Hall | Chief Medical Officer | 9,330 | $4.41 | $783.1M | -19.39% | +205.75% | $41.1K | -6.41% | — | Stalk |
| Mar 1, 2026 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 677 | $2.87 | $783.1M | -19.39% | +205.75% | $1.9K | -0.36% | — | Stalk |
| Feb 3, 2026 | Sell | ACRS | James Loerop | Chief Business Officer | 5,937 | $3.47 | $783.1M | -19.39% | +205.75% | $20.6K | -2.28% | — | Stalk |
| Feb 3, 2026 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 6,449 | $3.47 | $783.1M | -19.39% | +205.75% | $22.4K | -2.50% | — | Stalk |
| Feb 3, 2026 | Sell | ACRS | Neal Walker | CEO | 18,611 | $3.47 | $783.1M | -19.39% | +205.75% | $64.6K | -1.06% | — | Stalk |
| Feb 1, 2026 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 4,984 | $3.51 | $783.1M | -19.39% | +205.75% | $17.5K | -2.44% | — | Stalk |
| Feb 1, 2026 | Sell | ACRS | James Loerop | Chief Business Officer | 10,686 | $3.51 | $783.1M | -19.39% | +205.75% | $37.5K | -4.75% | — | Stalk |
| Jan 2, 2026 | Sell | ACRS | Neal Walker | CEO | 9,952 | $2.88 | $783.1M | -19.39% | +205.75% | $28.7K | -0.65% | — | Stalk |
| Dec 31, 2025 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 26,645 | $2.99 | $783.1M | -19.39% | +205.75% | $79.6K | -5.26% | — | Stalk |
| Dec 31, 2025 | Sell | ACRS | James Loerop | Chief Business Officer | 40,165 | $2.99 | $783.1M | -19.39% | +205.75% | $120.1K | -11.25% | — | Stalk |
| May 1, 2025 | Sell | ACRS | Neal Walker | CEO | 2,975 | $1.38 | $783.1M | -19.39% | +205.75% | $4.1K | -0.20% | — | Stalk |
| Apr 1, 2025 | Sell | ACRS | Neal Walker | CEO | 3,042 | $1.48 | $783.1M | -19.39% | +205.75% | $4.5K | -0.20% | — | Stalk |
| Mar 1, 2025 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 727 | $1.99 | $783.1M | -19.39% | +205.75% | $1.4K | -0.76% | — | Stalk |
| Mar 1, 2025 | Sell | ACRS | Neal Walker | CEO | 3,277 | $1.99 | $783.1M | -19.39% | +205.75% | $6.5K | -0.22% | — | Stalk |
| Mar 1, 2025 | Sell | ACRS | Joseph Monahan | Chief Scientific Officer | 27,258 | $1.99 | $783.1M | -19.39% | +205.75% | $54.2K | -8.97% | — | Stalk |
| Feb 1, 2025 | Sell | ACRS | Neal Walker | INTERIM CEO | 3,559 | $2.48 | $783.1M | -19.39% | +205.75% | $8.8K | -0.14% | — | Stalk |
| Feb 1, 2025 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 5,816 | $2.48 | $783.1M | -19.39% | +205.75% | $14.4K | -1.08% | — | Stalk |
| Feb 1, 2025 | Sell | ACRS | Joseph Monahan | Chief Scientific Officer | 11,317 | $2.48 | $783.1M | -19.39% | +205.75% | $28.1K | -1.66% | — | Stalk |
| Feb 1, 2025 | Sell | ACRS | James Loerop | Chief Business Officer | 15,447 | $2.48 | $783.1M | -19.39% | +205.75% | $38.3K | -2.73% | — | Stalk |
| Feb 1, 2025 | Sell | ACRS | James Loerop | Chief Business Officer | 15,980 | $2.48 | $783.1M | -19.39% | +205.75% | $39.6K | -13.46% | — | Stalk |
| Feb 1, 2025 | Sell | ACRS | James Loerop | Chief Business Officer | 15,980 | $2.48 | $783.1M | -19.39% | +205.75% | $39.6K | -13.46% | — | Stalk |
| Jan 1, 2025 | Sell | ACRS | Neal Walker | INTERIM CEO | 17,436 | $2.48 | $783.1M | -19.39% | +205.75% | $43.2K | -0.56% | — | Stalk |
| Dec 31, 2024 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 38,221 | $2.48 | $783.1M | -19.39% | +205.75% | $94.8K | -9.21% | — | Stalk |
| Dec 31, 2024 | Sell | ACRS | James Loerop | Chief Business Officer | 40,664 | $2.48 | $783.1M | -19.39% | +205.75% | $100.8K | -11.07% | — | Stalk |
| Dec 31, 2024 | Sell | ACRS | Joseph Monahan | Chief Scientific Officer | 41,851 | $2.48 | $783.1M | -19.39% | +205.75% | $103.8K | -6.57% | — | Stalk |
| Dec 10, 2024 | Sell | ACRS | Joseph Monahan | Chief Scientific Officer | 15,000 | $3.63 | $783.1M | -19.39% | +205.75% | $54.5K | -8.03% | — | Stalk |
| Dec 4, 2024 | Buy | ACRS | Neal Walker | INTERIM CEO | 187,183 | $2.34 | $783.1M | -19.39% | +205.75% | $437.6K | +1.75% | — | Stalk |
| Dec 1, 2024 | Sell | ACRS | Neal Walker | INTERIM CEO | 2,721 | $4.07 | $783.1M | -19.39% | +205.75% | $11.1K | -0.19% | — | Stalk |
| Nov 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 2,721 | $2.09 | $783.1M | -19.39% | +205.75% | $5.7K | -0.19% | — | Stalk |
| Oct 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 2,722 | $1.18 | $783.1M | -19.39% | +205.75% | $3.2K | -0.19% | — | Stalk |
| Sep 1, 2024 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 286 | $1.18 | $783.1M | -19.39% | +205.75% | $337.48 | -1.14% | — | Stalk |
| Sep 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 2,722 | $1.18 | $783.1M | -19.39% | +205.75% | $3.2K | -0.19% | — | Stalk |
| Aug 9, 2024 | Buy | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 43,548 | $0.72 | $783.1M | -19.39% | +205.75% | $31.4K | +3.32% | — | Stalk |
| Aug 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 2,722 | $1.32 | $783.1M | -19.39% | +205.75% | $3.6K | -0.19% | — | Stalk |
| Jul 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 2,722 | $1.15 | $783.1M | -19.39% | +205.75% | $3.1K | -0.19% | — | Stalk |
| Jun 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 2,722 | $1.03 | $783.1M | -19.39% | +205.75% | $2.8K | -0.19% | — | Stalk |
| May 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 2,784 | $1.26 | $783.1M | -19.39% | +205.75% | $3.5K | -0.20% | — | Stalk |
| Apr 1, 2024 | Sell | ACRS | Neal Walker | INTERIM PRESIDENT AND CEO | 3,224 | $1.26 | $783.1M | -19.39% | +205.75% | $4.1K | -0.23% | — | Stalk |
| Mar 1, 2024 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 1,417 | $1.24 | $783.1M | -19.39% | +205.75% | $1.8K | -1.88% | — | Stalk |
| Mar 1, 2024 | Sell | ACRS | Neal Walker | Interim President and CEO | 3,223 | $1.24 | $783.1M | -19.39% | +205.75% | $4.0K | -0.23% | — | Stalk |
| Mar 1, 2024 | Sell | ACRS | Joseph Monahan | Chief Scientific Officer | 21,283 | $1.24 | $783.1M | -19.39% | +205.75% | $26.4K | -3.39% | — | Stalk |
| Feb 1, 2024 | Sell | ACRS | Joseph Monahan | Chief Scientific Officer | 2,583 | $1.20 | $783.1M | -19.39% | +205.75% | $3.1K | -0.45% | — | Stalk |
| Feb 1, 2024 | Sell | ACRS | James Loerop | Chief Business Officer | 6,421 | $1.20 | $783.1M | -19.39% | +205.75% | $7.7K | -1.22% | — | Stalk |
| Jan 1, 2024 | Sell | ACRS | Kevin Balthaser | Chief Financial Officer | 2,536 | $1.05 | $783.1M | -19.39% | +205.75% | $2.7K | -5.58% | — | Stalk |
| Jan 1, 2024 | Sell | ACRS | Douglas J. Manion | Pres and CEO | 9,125 | $1.05 | $783.1M | -19.39% | +205.75% | $9.6K | -6.92% | — | Stalk |
| Oct 23, 2023 | Sell | ACRS | Joseph Monahan | Chief Scientific Officer | 6,000 | $5.08 | $783.1M | -19.39% | +205.75% | $30.5K | -4.42% | 10b5-1 | Stalk |